Latest therapeutics News | Page 3

HKUST Receives Government’s Approval to Establish a New Medical School
HKUST Receives Government’s Approval for Establishing a New Medical School
HKUST Received Government’s Approval for Establishing a New Medical School
HKUST Granted Approval to Establish a New Medical School
Targeting Matrix For Anti-tumor T Cell Revival
Monash spinout RAGE Biotech secures $29 million to advance next-generation RNA therapeutics
Switchbody: an enzyme fragment-fused antibody for antigen-responsive enzyme switch
The science of weight loss – and why your brain is wired to keep you fat
Researchers Unveil Powerful New Gene-switch Tool
World-first RNA Trial Breakthrough For Lupus Patients
World-First RNA Trial Breakthrough For Lupus Patients
Thesis on exercise-induced EVs and their protective role against diabetes
MERS-CoV virus isolate added to the WHO BioHub System, enabling further research and pandemic preparedness
Finding Could Help Avert Melanoma Relapses
Antidepressants: physical side-effects vary depending on the drug type – new research
AusBiotech Invest kicks off Australia’s biggest week in biotech
AdvanCell Appoints Experienced Biotech And Pharma Leader, Andrew Kay, As Chair Of Board Of Directors
Human Gut Virus Discoveries Open New Field Of Microbiome Medicine
UNSW Takes Home Two Gongs At National Chemistry Awards
QIMR Berghofer Science Powers Breakthrough In Cancer Immunotherapy
LICR, CHUV And UNIL Are Extending Their Collaboration And Renewing Their Partnership
Tackling Inflammation In Gut: Role Of ‘unconventional’ Immune Cells
AI Tool Designed To Identify Buyer Behaviour Reimagined To Discover Medicine Safety And Repurposing Opportunities
How Psychedelics Could Revolutionise Anti-inflammatory Medicine
Some Human GII.4 Norovirus Are Better Than Others At Infecting Cells
AusBiotech Welcomes New Members In Third Quarter
AusBiotech And Medicines Australia Launch New Advisory Group To Accelerate Advanced Therapies
A new analytical tool to optimize the potency and selectivity of drugs
AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25
Member States advance vital work in support of WHO Pandemic Agreement
Baylor College of Medicine announces Dr. Paul Klotman’s retirement as president
South Korea’s K-Bio Lab Hub forms MoU with Monash University
Korea’s K-Bio Lab Hub Forms MoU With Monash University
AIID marks significant planning milestone in facility development
Forging a better life ― Future carved out through resonance of medicine and science
New trial aims to advance research into Strep A vaccine development
Survival Kit For Smallpox Viruses
CUREator BioTech Incubator Grants $1.23M Top-Up Funding to High-Performing Participants
CUREator backs Monash biotech to advance new therapeutics for polycystic kidney disease
Speech from Minister Butler, Australian Parliament House – 3 September 2025
Protein discovery gives new hope for longer COVID protection
$72 million for medical research into deadly venom, Parkinson’s disease and more
Insights into the role of PAD2-mediated histone citrullination in pancreatic cancer progression
AI reveals how protein modifications link mutations to disease
Bioengineered bacteria could lead to therapeutic antibody drugs
Can Antibodies Hold Key To Curing Paediatric Glioma?
Unlocking interoperability: The key to seamless health data exchange
Monash wins for Research Commercialisation at AFR Higher Education Awards